Eighty-five percent of diagnosed cases of lung cancer are non-small cell lung cancer (NSCLC). In this group, 5% of patients show molecular alterations in the ALK gene involved in cell multiplication.

In a report released today, Matt Hewitt from Craig-Hallum reiterated a Buy rating on Lifecore Biomedical (LFCR – Research Report), with a price ...

President Trump attended a National Republican Congressional Committee event and during his speech commented that he will announce large ...